{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:39:12Z","timestamp":1792723152762,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["JDZX2015114"],"award-info":[{"award-number":["JDZX2015114"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470306"],"award-info":[{"award-number":["81470306"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670138"],"award-info":[{"award-number":["81670138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870111"],"award-info":[{"award-number":["81870111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.biopha.2020.111054","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T18:44:10Z","timestamp":1606502650000},"page":"111054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Natural small molecule triptonide inhibits lethal acute myeloid leukemia with FLT3-ITD mutation by targeting Hedgehog\/FLT3 signaling"],"prefix":"10.1016","volume":"133","author":[{"given":"Ying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.111054_bib0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41375-018-0357-9","article-title":"Targeting FLT3 mutations in AML: review of current knowledge and evidence","volume":"33","author":"Daver","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2020.111054_bib0010","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/blood.2019001282","article-title":"PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD(+) acute myeloid leukemia","volume":"134","author":"He","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2020.111054_bib0015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.111054_bib0020","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2020.111054_bib0025","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1158\/2159-8290.CD-17-0841","article-title":"Targeting the MTF2-MDM2 Axis Sensitizes refractory acute myeloid leukemia to chemotherapy","volume":"8","author":"Maganti","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2020.111054_bib0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccell.2018.08.007","article-title":"Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence","volume":"34","author":"Boyd","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2020.111054_bib0035","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1182\/blood-2013-07-513044","article-title":"Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemia","volume":"122","author":"Zimmerman","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2020.111054_bib0040","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1902688","article-title":"Gilteritinib or chemotherapy for relapsed or refractory FLT3-Mutated AML","volume":"381","author":"Perl","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.111054_bib0045","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1182\/blood-2017-05-782292","article-title":"Midostaurin approved for FLT3-mutated AML","volume":"129","author":"Levis","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2020.111054_bib0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1614359","article-title":"Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation","volume":"377","author":"Stone","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.111054_bib0055","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1182\/blood-2018-01-821629","article-title":"Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD-mutated, relapsed or refractory AML","volume":"132","author":"Cortes","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2020.111054_bib0060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41467-018-08263-x","article-title":"Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2020.111054_bib0065","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(17)30416-3","article-title":"Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study","volume":"18","author":"Perl","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2020.111054_bib0070","doi-asserted-by":"crossref","DOI":"10.3390\/cells8040312","article-title":"Targeting hedgehog (Hh) pathway for the acute myeloid leukemia treatment","volume":"8","author":"Terao","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2020.111054_bib0075","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia","volume":"458","author":"Zhao","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.111054_bib0080","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1158\/1078-0432.CCR-14-1059","article-title":"Expression of hedgehog pathway mediator GLI represents a negative prognostic marker in human acute myeloid leukemia and its inhibition exerts antileukemic effects","volume":"21","author":"Wellbrock","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.111054_bib0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa5731","article-title":"Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia","volume":"7","author":"Lim","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2020.111054_bib0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.fct.2018.03.009","article-title":"Comparative metabolism of tripolide and triptonide using metabolomics","volume":"115","author":"Hu","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2020.111054_bib0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcp.2016.11.024","article-title":"Targeting of multiple senescence-promoting genes and signaling pathways by triptonide induces complete senescence of acute myeloid leukemia cells","volume":"126","author":"Pan","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2020.111054_bib0100","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/pros.23834","article-title":"Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway","volume":"79","author":"Dong","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2020.111054_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2019.01.002","article-title":"Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway","volume":"365","author":"Zhang","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2020.111054_bib0110","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia","volume":"350","author":"Valk","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.111054_bib0115","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.111054_bib0120","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1158\/0008-5472.CAN-14-2486","article-title":"CDK4\/6 inhibitor PD 0332991 sensitizes acute myeloid leukemia to cytarabine-mediated cytotoxicity","volume":"75","author":"Yang","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2020.111054_bib0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061596","article-title":"Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4\/6 Inhibitors","volume":"12","author":"Sorf","year":"2020","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.biopha.2020.111054_bib0130","first-page":"5867","article-title":"Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation","volume":"62","author":"Louro","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2020.111054_bib0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2164-13-2","article-title":"Yeast-based assay identifies novel Shh\/Gli target genes in vertebrate development","volume":"13","author":"Milla","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.biopha.2020.111054_bib0140","doi-asserted-by":"crossref","first-page":"9489","DOI":"10.1038\/srep09489","article-title":"GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1","volume":"5","author":"Kumar","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.111054_bib0145","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1073\/pnas.0712216105","article-title":"Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2","volume":"105","author":"Abe","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.biopha.2020.111054_bib0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchembio.522","article-title":"XPB, a subunit of TFIIH, is a target of the natural product triptolide","volume":"7","author":"Titov","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2020.111054_bib0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","article-title":"SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells","volume":"15","author":"Li","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biopha.2020.111054_bib0160","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.celrep.2019.07.001","article-title":"Integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas","volume":"28","author":"Donehower","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2020.111054_bib0165","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/leu.2016.350","article-title":"p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status","volume":"31","author":"Quintas-Cardama","year":"2017","journal-title":"Leukemia"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220312464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220312464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:13:25Z","timestamp":1792721605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220312464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":33,"alternative-id":["S0753332220312464"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111054","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural small molecule triptonide inhibits lethal acute myeloid leukemia with FLT3-ITD mutation by targeting Hedgehog\/FLT3 signaling","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111054"}}